Iranian company unveils new drug to treat diabetes, obesity Story by Susan Mbamah An Iranian knowledge-based company has unveiled a homegrown medicine aimed at treatment of patients suffering from diabetes mellitus type 2, commonly known as type 2 diabetes (T2D), obesity as well as sleep apnea. The new product, dubbed Spartina, was put on display during a ceremony held at the Imam Khomeini Hospital Complex in Tehran on Monday. The drug reportedly contains the active ingredient tirzepatide, which is produced by a domestic knowledge-based firm. Tirzepatide is said to be the first and only...